Table of Contents

2019-2024 Global Radiopharmaceutical Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Radiopharmaceutical Consumption 2014-2024
  • 2.1.2 Radiopharmaceutical Consumption CAGR by Region
• 2.2 Radiopharmaceutical Segment by Type
  • 2.2.1 Actinium-225
  • 2.2.2 Lutetium-177
  • 2.2.3 Radium-223
  • 2.2.4 Holmium-166
  • 2.2.5 Other
• 2.3 Radiopharmaceutical Consumption by Type
  • 2.3.1 Global Radiopharmaceutical Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Radiopharmaceutical Sale Price by Type (2014-2019)
• 2.4 Radiopharmaceutical Segment by Application
  • 2.4.1 Oncology
  • 2.4.2 Cardiology
  • 2.4.3 Other
• 2.5 Radiopharmaceutical Consumption by Application
  • 2.5.1 Global Radiopharmaceutical Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Radiopharmaceutical Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Radiopharmaceutical Sale Price by Application (2014-2019)

3 Global Radiopharmaceutical by Players

• 3.1 Global Radiopharmaceutical Sales Market Share by Players
  • 3.1.1 Global Radiopharmaceutical Sales by Players (2017-2019)
  • 3.1.2 Global Radiopharmaceutical Sales Market Share by Players (2017-2019)
• 3.2 Global Radiopharmaceutical Revenue Market Share by Players
  • 3.2.1 Global Radiopharmaceutical Revenue by Players (2017-2019)
  • 3.2.2 Global Radiopharmaceutical Revenue Market Share by Players (2017-2019)
• 3.3 Global Radiopharmaceutical Sale Price by Players
• 3.4 Global Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Radiopharmaceutical Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Radiopharmaceutical by Regions

• 4.1 Radiopharmaceutical by Regions
  • 4.1.1 Global Radiopharmaceutical Consumption by Regions
  • 4.1.2 Global Radiopharmaceutical Value by Regions
• 4.2 Americas Radiopharmaceutical Consumption Growth
• 4.3 APAC Radiopharmaceutical Consumption Growth
• 4.4 Europe Radiopharmaceutical Consumption Growth
• 4.5 Middle East & Africa Radiopharmaceutical Consumption Growth

5 Americas

• 5.1 Americas Radiopharmaceutical Consumption by Countries
  • 5.1.1 Americas Radiopharmaceutical Consumption by Countries (2014-2019)
  • 5.1.2 Americas Radiopharmaceutical Value by Countries (2014-2019)
• 5.2 Americas Radiopharmaceutical Consumption by Type
• 5.3 Americas Radiopharmaceutical Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Radiopharmaceutical Consumption by Countries
  • 6.1.1 APAC Radiopharmaceutical Consumption by Countries (2014-2019)
  • 6.1.2 APAC Radiopharmaceutical Value by Countries (2014-2019)
• 6.2 APAC Radiopharmaceutical Consumption by Type
• 6.3 APAC Radiopharmaceutical Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Radiopharmaceutical by Countries
  • 7.1.1 Europe Radiopharmaceutical Consumption by Countries (2014-2019)
  • 7.1.2 Europe Radiopharmaceutical Value by Countries (2014-2019)
• 7.2 Europe Radiopharmaceutical Consumption by Type
• 7.3 Europe Radiopharmaceutical Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Radiopharmaceutical by Countries
  • 8.1.1 Middle East & Africa Radiopharmaceutical Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Radiopharmaceutical Value by Countries (2014-2019)
• 8.2 Middle East & Africa Radiopharmaceutical Consumption by Type
• 8.3 Middle East & Africa Radiopharmaceutical Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Radiopharmaceutical Distributors
• 10.3 Radiopharmaceutical Customer

11 Global Radiopharmaceutical Market Forecast

• 11.1 Global Radiopharmaceutical Consumption Forecast (2019-2024)
• 11.2 Global Radiopharmaceutical Forecast by Regions
  • 11.2.1 Global Radiopharmaceutical Forecast by Regions (2019-2024)
  • 11.2.2 Global Radiopharmaceutical Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Radiopharmaceutical Forecast by Type
• 11.8 Global Radiopharmaceutical Forecast by Application

12 Key Players Analysis

• 12.1 Bracco Imaging
  • 12.1.1 Company Details
  • 12.1.2 Radiopharmaceutical Product Offered
  • 12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bracco Imaging News
• 12.2 Bayer
  • 12.2.1 Company Details
  • 12.2.2 Radiopharmaceutical Product Offered
  • 12.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Bayer News
• 12.3 Mallinckrodt
  • 12.3.1 Company Details
  • 12.3.2 Radiopharmaceutical Product Offered
  • 12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Mallinckrodt News
• 12.4 Nordion
  • 12.4.1 Company Details
  • 12.4.2 Radiopharmaceutical Product Offered
  • 12.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Nordion News
• 12.5 Triad Isotopes
  • 12.5.1 Company Details
  • 12.5.2 Radiopharmaceutical Product Offered
  • 12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Triad Isotopes News
• 12.6 Lantheus
  • 12.6.1 Company Details
  • 12.6.2 Radiopharmaceutical Product Offered
  • 12.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Lantheus News
• 12.7 IBA Group
  • 12.7.1 Company Details
  • 12.7.2 Radiopharmaceutical Product Offered
  • 12.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 IBA Group News
• 12.8 GE Healthcare
  • 12.8.1 Company Details
  • 12.8.2 Radiopharmaceutical Product Offered
  • 12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 GE Healthcare News
• 12.9 China Isotope & Radiation
  • 12.9.1 Company Details
  • 12.9.2 Radiopharmaceutical Product Offered
  • 12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 China Isotope & Radiation News
• 12.10 Jubilant Pharma
  • 12.10.1 Company Details
  • 12.10.2 Radiopharmaceutical Product Offered
  • 12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Jubilant Pharma News
• 12.11 Eli Lilly
• 12.12 Advanced Accelerator Applications
• 12.13 SIEMENS
• 12.14 Dongcheng
• 12.15 Navidea

13 Research Findings and Conclusion

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

According to this study, over the next five years the Radiopharmaceutical market will register a 8.7% CAGR in terms of revenue, the global market size will reach US$ 8120 million by 2024, from US$ 4940 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceutical business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.

This study considers the Radiopharmaceutical value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Radiopharmaceutical consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Radiopharmaceutical market by identifying its various subsegments.
Focuses on the key global Radiopharmaceutical manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceutical with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceutical submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.